Odyssey Health Inc Financials
This page shows Odyssey Health Inc (ODYY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
The reported balance sheet shows a shrinking asset base alongside rising liabilities and recurring dependence on financing.
From FY2022 through FY2024, operating cash flow stayed negative while financing cash flow stayed positive; that pairing indicates the reported operating model was not self-funding, with financing providing the offset. The important shift is that financing did not stabilize the balance sheet as assets continued to contract and liabilities increased.
By FY2025, total assets had fallen from
In FY2024, the operating loss was
Financial Health Signals
Odyssey Health Inc does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The metrics below are current.
Key Financial Metrics
Earnings & Revenue
Odyssey Health Inc earned -$0.02 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 100.0% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Odyssey Health Inc held $19K in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
None of these metrics is reported for fiscal year 2025.
Capital Allocation
Odyssey Health Inc reported no research and development spending in fiscal year 2025. This represents a decrease of 100.0% from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
ODYY Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| R&D Expenses | N/A | N/A | N/A | N/A | $0 | $0 | $0 | N/A |
| SG&A Expenses | $298K+63.5% | $182K-40.0% | $303K | N/A | $129K-17.6% | $157K-73.0% | $579K | N/A |
| Operating Income | -$298K-63.5% | -$182K+40.0% | -$303K | N/A | -$129K+17.6% | -$157K+73.0% | -$579K | N/A |
| Interest Expense | $528K+27.9% | $412K+332.6% | $95K | N/A | $61K-3.2% | $63K-7.8% | $69K | N/A |
| Net Income | $766K+121.3% | -$3.6M-645.0% | -$483K | N/A | -$252K-14.4% | -$220K+78.4% | -$1.0M | N/A |
| EPS (Diluted) | $0.01 | -$0.03 | $0.00+100.0% | -$0.01 | $0.00 | $0.00+100.0% | -$0.01+91.7% | -$0.12 |
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, Income Tax.
ODYY Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $374K-48.2% | $721K+402.2% | $144K+188.8% | $50K-69.8% | $165K-38.4% | $267K-21.8% | $341K-41.8% | $586K |
| Current Assets | $374K-48.2% | $721K+402.2% | $144K+188.8% | $50K-26.2% | $67K-37.8% | $108K-40.6% | $183K+220.6% | $57K |
| Cash & Equivalents | $298K-51.7% | $616K+2308.8% | $26K+34.1% | $19K+499.0% | $3K-55.7% | $7K-86.7% | $54K+2164.2% | $2K |
| Total Liabilities | $10.1M-10.5% | $11.3M+55.1% | $7.3M+4.2% | $7.0M+207.1% | -$6.5M-197.2% | $6.7M+1.7% | $6.6M+11.8% | $5.9M |
| Current Liabilities | $10.1M-10.5% | $11.3M+55.1% | $7.3M+4.2% | $7.0M+2.0% | $6.9M+2.0% | $6.7M+1.7% | $6.6M+11.8% | $5.9M |
| Total Equity | -$9.7M+8.0% | -$10.6M-48.1% | -$7.2M-2.9% | -$7.0M-203.8% | $6.7M+203.7% | -$6.5M-2.9% | -$6.3M-17.7% | -$5.3M |
| Retained Earnings | -$66.1M+1.1% | -$66.8M-5.7% | -$63.2M-0.8% | -$62.7M-0.4% | -$62.5M-0.4% | -$62.2M-0.4% | -$62.0M-1.7% | -$61.0M |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.
ODYY Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$319K-12.1% | -$284K-0.1% | -$284K-489.2% | -$48K-1104.7% | -$4K+91.4% | -$47K+81.2% | -$249K-290.5% | -$64K |
| Investing Cash Flow | N/A | N/A | N/A | $70K | $0 | N/A | N/A | $0 |
| Financing Cash Flow | $0-100.0% | $875K+201.2% | $291K+5205.4% | -$6K | $0 | $0-100.0% | $300K | $0 |
| Dividends Paid | N/A | N/A | N/A | N/A | $0 | $0 | N/A | N/A |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Share Buybacks.
ODYY Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity | N/A | N/A | N/A | N/A | -3.8% | N/A | N/A | N/A |
| Return on Assets | 204.9%+704.2pp | -499.3%-162.7pp | -336.6% | N/A | -153.0%-70.5pp | -82.5%+216.3pp | -298.8% | N/A |
| Current Ratio | 0.040.0x | 0.060.0x | 0.020.0x | 0.010.0x | 0.010.0x | 0.020.0x | 0.030.0x | 0.01 |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Debt-to-Equity, FCF Margin.
Note: Shareholder equity is negative (-$7.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Where Odyssey Health Inc Ranks
Frequently Asked Questions
What are Odyssey Health Inc's total assets?
Odyssey Health Inc (ODYY) had $50K in total assets as of fiscal year 2025, including both current and long-term assets.
What is Odyssey Health Inc's current ratio?
Odyssey Health Inc (ODYY) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
Why is Odyssey Health Inc's debt-to-equity ratio negative or not reported?
Odyssey Health Inc (ODYY) has negative shareholder equity of -$7.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.